|
|
Volumn 351, Issue 3, 2004, Pages 211-213
|
|
The business of stem cells
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CLONING;
EMBRYO (ANATOMY);
ETHICS;
MEDICAL RESEARCH;
POLICY;
PRIORITY JOURNAL;
REVIEW;
STEM CELL;
ARTICLE;
BIOMEDICAL AND BEHAVIORAL RESEARCH;
CELL LINE;
COMMERCIAL PHENOMENA;
CYTOLOGY;
ECONOMICS;
EMBRYO;
EMBRYO RESEARCH;
FINANCIAL MANAGEMENT;
GENETICS AND REPRODUCTION;
GOVERNMENT;
HEALTH CARE POLICY;
HUMAN;
LEGAL ASPECT;
MORALITY;
UNITED STATES;
BIOMEDICAL AND BEHAVIORAL RESEARCH;
GENETICS AND REPRODUCTION;
CELL LINE;
CLONING, ORGANISM;
COMMERCE;
EMBRYO;
EMBRYO RESEARCH;
FEDERAL GOVERNMENT;
FINANCING, GOVERNMENT;
HEALTH POLICY;
HUMANS;
MORALS;
RESEARCH SUPPORT;
STEM CELLS;
UNITED STATES;
|
|
EID: 3142710379
PISSN: 00284793
EISSN: None
Source Type: Journal
DOI: 10.1056/NEJMp048138 Document Type: Review |
|
Times cited : (10)
|
|
References (0)
|
